Current issues regarding the application of recombinant lactic acid bacteria to mucosal vaccine carriers

Keita Takahashi(Gifu Pharmaceutical University), Naoki Inoue(Mukogawa Women's University), Nozomi Orito(Gifu Pharmaceutical University), Nagisa Tokunoh(Gifu Pharmaceutical University)
Applied Microbiology and Biotechnology
June 7, 2019
10.1007/s00253-019-09912-x
Cited by 21

Related Papers

Human Herpesvirus 6B Genome Sequence: Coding Content and Comparison with Human Herpesvirus 6A
|Journal of Virology|1999|342
ICTV Virus Taxonomy Profile: Herpesviridae 2021
|Journal of General Virology|2021|255
Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
|Clinical Cancer Research|2015|180
Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis
|Nature Medicine|1999|176
Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS
|Blood|2017|169